![](/img/cover-not-exists.png)
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial
Mato, Anthony R., Roeker, Lindsey E., Allan, John N., Pagel, John M., Brander, Danielle M., Hill, Brian T., Cheson, Bruce D., Furman, Richard R., Lamanna, Nicole, Tam, Constantine S., Handunnetti, SasJournal:
American Journal of Hematology
DOI:
10.1002/ajh.25261
Date:
August, 2018
File:
PDF, 1.72 MB
2018